British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing, China.
BUSINESS
China Explores Limiting Its Own Exports to Mollify Trump
Chinese officials weigh Japan’s 1980s strategy—restraining exports while charging more—for products such as electric vehicles or batteries.
‘Greatest brand destruction of our times’: Musk’s Tesla China crisis
Tesla is losing the innovation race to BYD as production and sales fall in China, the world’s biggest car market.
China urges expansion of digital yuan usage beyond retail to challenge U.S. dollar stablecoins
China is increasing its efforts to strengthen its digital yuan. It aims to challenge US dollar-pegged stablecoins in world trade.
Left loses it over possibility of Musk top secret China briefing: ‘No business’
D-N.Y., said SpaceX and Tesla CEO Elon Musk has “no business” conducting affairs at the Pentagon, amid reports Musk would receive secret information from top military officials Friday about military contingency plans should a war…
Musk has ‘no business’ in Pentagon, Dems say amid report he’d get top secret China briefing
While the New York Times reported that Musk was set to receive details about a potential China conflict, the Pentagon and White House pushed back and said Musk’s briefing wouldn’t cover China.
Elon and Trump debunk NYT story about DOGE strategizing on war with China, promise prosecutions
Donald Trump and Elon Musk both went off on Thursday night after The New York Times published a story claiming Elon was heading to the Pentagon for a classified meeting about war with China.
Trump sharply denies Musk China briefing, citing business conflicts
President Trump on Friday denied that his administration would show billionaire Elon Musk details of the Pentagon’s planning for a potential war with China, citing Musk’s various business dealings …
Vietnam Cops Probe Chinese Tea Brand Over South China Sea Map
Vietnamese police are investigating a Chinese tea brand over an online map featuring Beijing’s disputed claims in the South China Sea, authorities said.
Biotech designed to commercialize Ascendis’ endocrinology drugs in China files $86M IPO
Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 million IPO. | Endocrine-disease-focused Visen Pharmaceuticals is making its …
PomDoctor Begins $15 Million U.S. IPO Rollout
Discover how PomDoctor Limited aims to revolutionize China’s telehealth industry with a $15M IPO, despite facing stiff competition. Read more on the POM IPO.
China Imports of US Commodities, Cars Collapse in New Trade War
China’s imports of US cotton, cars and some energy products all plunged in the first two months of the year after President Donald Trump started imposing tariffs and Beijing retaliated.
‘Who Will Come to Invest?’ China’s Attacks on Panama Canal Deal Alarm Hong Kong
Beijing’s threat to stop a tycoon’s sale of his ports business has dealmakers wondering if they can still operate without political interference.
